SENSEX NIFTY

Glenmark Pharmaceuticals

Sep 22, 2014 at 12:32 | Source: CNBC-TV18
According to Sandeep Bhatia, Executive Director & Head of Sales at Kotak Institutional Equities, one may prefer Cadilla Healthcare and Cipla from the pharma space.
Sep 22, 2014 at 12:30 | Source: CNBC-TV18
Sandeep Bhatia, Executive Director & Head of Sales at Kotak Institutional Equities is of the view that one may prefer Glenmark Pharma and DCB Bank.
Sep 18, 2014 at 12:18 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, capital goods stocks like Crompton Greaves, Siemens, ABB, Bharat Heavy Electricals and Havells India will be getting astrological support.
Sep 18, 2014 at 11:15 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Glenmark Pharma.
Sep 10, 2014 at 12:51 | Source: Moneycontrol.com
Sharekhan has recommended hold rating on Glenmark Pharma with a target of Rs 805, in its research report dated September 09, 2014.
Sep 05, 2014 at 12:02 | Source: CNBC-TV18
Pankaj Jain of Sunteck Wealthmax recommends going long in Sona Koyo Steering Systems for a target of Rs 55 and Glenmark Pharma for a target of Rs 799.
Sep 04, 2014 at 11:07 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, technology stocks like Tata Consultancy Services, Tech Mahindra, Infosys, Oracle Financial Services Software and Persistent System will get astrological suppport.
Sep 03, 2014 at 10:03 | Source: CNBC-TV18
According to Sudarshan Sukhani of s2analytics.com, one may get in to Glenmark Pharma and stay invested in it.
Aug 26, 2014 at 15:25 | Source: Moneycontrol.com
According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high long-term growth, subject to timely regulatory approval.
Aug 25, 2014 at 11:12 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, technology sector will be receiving strong astrological support and advises buyingg Tata Consultancy Services, Tech Mahindra, Infosys, HCL Technologies, Polaris Financial Technology, Geometric, Mastek and CMC.
Messages on Glenmark Pharmaceuticals »

BSE/NSE Announcer

Platinum Member

4330 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding the press release dated July 08, 2014 titled,"Glenmark Generics receives final ANDA approval for Telmisartan Tablets."

12.41 PM Jul 8th

BSE/NSE Announcer

Platinum Member

4330 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets" Glenmark Generics Inc., USA a subsidiary of Glenmark Generics has been granted final abbreviated new drug approval (ANDA) from

12.04 PM Jul 8th

phs25

Gold Member

9 Followers

Glenmark  

Glenmark Generics receives final ANDA approval for Telmisartan Tablets | 07/08/14 12:01 Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 08, 2014 titled "Glenmark Generics receives final ANDA approval for Telmisartan Tablets

12.03 PM Jul 8th

BSE/NSE Announcer

Platinum Member

4330 Followers

Glenmark  

Glenmark Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2014.

11.48 AM Jul 8th

BSE/NSE Announcer

Platinum Member

4330 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated July 03, 2014 titled "Glenmarks novel monoclonal antibody GBR 830 for treatment of autoimmune diseases entering human trials"

5.57 PM Jul 3rd

BSE/NSE Announcer

Platinum Member

4330 Followers

Glenmark  

The Register of Members & Share Transfer Books of Glenmark Pharmaceuticals will remain closed from July 14, 2014 to July 25, 2014 (both days inclusive) for the purpose of Payment of Dividend & 36th Annual General Meeting (AGM) of the Company to be held on July 25, 2014.

7.05 PM Jun 30th

adviserbola

Platinum Member

302 Followers

Marksans Pharma  

Did any body know Before promoting this venture Marksans Pharma, Mr. Mark Saldanha held the position of whole time Director at Glenmark Pharmaceuticals Ltd. Today Glenmark Pharma is trading above 570 Levels

10.32 PM Jun 11th

Jayan C

New Member

6 Followers

Just Posted  

Glenmark Pharmaceuticals has opened its new monoclonal antibody manufacturing facility in La Chaux-de-Fonds, Switzerland.

6.22 PM Jun 5th

Amrita Gaba

New Member

416 Followers

Glenmark  

Glenmark Pharmaceuticals S.A (GPSA), a wholly-owned subsidiary of Glenmark Pharmaceuticals Ltd. has opened its new GMP compliant monoclonal antibody manufacturing facility in La Chaux-de- Fonds, Switzerland. This manufacturing facility supplements Glenmark`s existing in-house discovery

12.57 PM Jun 5th

BSE/NSE Announcer

Platinum Member

4330 Followers

Glenmark  

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 04, 2014, titled"Glenmark Pharmaceuticals Inaugurates new Antibody Manufacturing Facility in La Chaux-de fonds, Switzerland".

11.11 AM Jun 4th

News across the web »
Aug 21, 2014 at 09:37 | Source: Calcutta Telegraph News
Aug 20, 2014 at 20:00 | Source: NDTV Profit
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.